Overview
Specialty materials firm's Q4 revenue fell, missing analyst expectations
Adjusted EPS for Q4 beat analyst expectations
Company returned $500 mln to shareholders via dividends and share repurchases
Outlook
Eastman expects 1Q26 adjusted EPS between $1.00 and $1.20
Company plans cost structure reductions of $125 mln to $150 mln in 2026
Eastman anticipates similar operating cash flow in 2026 as in 2025
Result Drivers
COST REDUCTIONS - Eastman exceeded its cost reduction goals, achieving $100 mln in savings, which helped offset lower sales volume and price impacts
KINGSPORT FACILITY - The Kingsport methanolysis facility met operational goals, producing over 2.5 times more and delivering $60 mln in incremental earnings
COMMERCIAL EXCELLENCE - Despite a weak economic environment, Eastman defended product value, maintaining prices and market share
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q4 Revenue
Miss
$1.97 bln
$2.02 bln (12 Analysts)
Q4 Adjusted EPS
Beat
$0.75
$0.72 (16 Analysts)
Q4 EPS
$0.92
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy", 10 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the specialty chemicals peer group is "buy"
Wall Street's median 12-month price target for Eastman Chemical Co is $72.00, about 4.3% above its January 28 closing price of $69.03
The stock recently traded at 11 times the next 12-month earnings vs. a P/E of 9 three months ago
Press Release: ID:nBw72CFm8a
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)